fda glp-1 warning letters november 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval The FDA sent a warning

All authors agree to be accountable for all aspects of work ensuring integrity and accuracy

3.4 Cancer progression and anti-tumor immunity The role of choline metabolism in cancer progression and growth has been extensively studied and revised elsewhere (201, 202)

Copper in solution tends to oxidize, and this oxidation can damage the peptide structure over time

Liposomal Glutathione acts as a systemic shield, neutralizing oxidative stress and preventing mitochondrial fatigue, which allows for higher sustained workloads and faster recovery

The single solvent dissolves all four peptides together, which keeps the fixed composition ratio intact